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Abstract. A single injection of low-dose dexamethasone on postnatal day 3 resulted in the upregulation of key apoptotic 
enzyme – active caspase-3 in the rat cortex 120 hours after injection, and was followed by a delayed development of 
neonatal startle reflex and cliff avoidance reaction, an arrest of body weight gain and reduced spontaneous locomotor 
activity of pups. A single hydrocortisone administration to neonatal rats was only followed by a short-term delay in body 
weight gain, with no changes in the levels of active caspase-3 in the cortex and brainstem, as well as with no 
abnormalities in neurodevelopment. These results evidence for lesser neurotoxicity of natural hormone during neonatal 
development in comparison with dexamethasone and suggest the possibility that hydrocortisone might be used as a 
substitution for its synthetic analogue in the perinatal medicine. 
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Introduction 
Synthetic glucocorticoid dexamethasone improves perinatal lung maturation and is widely 
used to prevent the respiratory distress syndrome in neonates (Jobe 2009). However, both 
clinical studies and laboratory animal researchs indicate that perinatal dexamethasone treatment 
can have deleterious effects on central nervous system and behavioral development (Watterberg 
2007; Noguchi et al. 2008; Jobe 2009). The damaging effects of dexamethasone may be related 
to the attenuation or augmentation of apoptosis – the naturally occurring cell death (Noguchi et 
al. 2008), which is much more active in the developing than in the adult mammalian brain 
(White & Barone 2001, Menshanov et al. 2006, Men’shanov et al. 2011). 
There are two possible ways to reduce the dexamethasone-related developmental 
neurotoxicity: 1) lowering the dosage of drug or 2) using a different steroid. However, the 
molecular and behavioral consequences of the administration of a single low-dose 
dexamethasone or hydrocortisone to neonatal rats are poorly understood. According to this, the 
goal of the present research was to study the effects of low-dose dexamethasone and 
hydrocortisone on general and psychomotor development of neonatal rats and the expression of 
the key apoptotic enzyme – procaspase-3 and its active form in the brain regions with high 
intensity of developmental apoptosis – brainstem and cortex. 
Materials and Methods 
Animals and treatment 
All animal procedures were in compliance with the European Communities Council 
Directive of 22.09.2010 (ЕС 2010/63/EU) and were approved by the institutional Animal Care 
and Use Committee. All efforts were made to minimize animal suffering and to use only the 
number of animals necessary to produce reliable data. Wistar rat pups raised in the colony of 
our institute were used in experiments. The colony was maintained under natural illumination at 
22-24ºC with food and water available ad libitum. The day of birth was considered as postnatal 
day 1 (PD1). Litters were culled to 8 pups on PD3. On PD8 animals were treated subcutaneously 
either with 5 mg/kg of hydrocortisone or 0.2 mg/kg of dexamethasone in 20 ul of saline. Control 
animals received an equal volume of saline. All rats were divided into two experimental groups. 
Animals of the first group were used for behavioral testing. Rats of the second group were used 
for biochemical determinations and were rapidly decapitated in 6, 24 or 120 hours after 
injection. Tissue samples – brainstem and cortex - were dissected out on a cooled plate and 
frozen in liquid nitrogen until further processing. 
Behavior testing 
To determine the effect of glucocorticoid administration on the postnatal psychomotor 
development of mice, all animals of the first group were assessed for behavioral changes with 
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tests included in the Fox's battery for rats (Fox 1965). All testing was performed between 10:00 
and 14:00 from PD4 till PD18. Moreover, body weight gain was determined each day after 
glucocorticoid administration. 
Righting reflex and Cliff drop aversion 
The animal was placed face up and the time taken to turn over to a prone position with 
all four feet on the floor was assessed. The maximum time allocated to perform the test was 60 
seconds. The pup was placed on the edge of the table with the forepaws and head extending 
over the edge. The response was scored as positive if the rat turned and crawled away at least 
90º from the “cliff”. The maximum time allocated to perform this test was 60 seconds. 
Negative geotaxis and Immunoblot analysis 
The animal was placed facing downwards on a 30º incline and the latency to turn 180º 
was recorded. The maximum time allocated to perform the test was 30 seconds. 
Spontaneous locomotor activity. The detection of locomotor activity was carried out in a warm 
(30°C) plastic chamber (30x20 cm) for 60 sec as described previously by Menshanov & Dygalo 
(2007). Brain tissue was homogenized in lysis buffer containing 150 mM NaCl, 50 mM Tris, 1% 
Triton X-100 and following protease inhibitors: 1 mM phenylmethylsulfonylfluoride and 2 µg/ml 
of leupeptin, pepstatin and aprotinin. Electrophoresis was used to separate aliquots (50 ug) of a 
total protein on 15% sodium dodecyl sulfate polyacrylamide gel. The resolved proteins were 
transferred on the nitrocellulose membrane by Transblot Cell (Bio-Rad Laboratories, USA). 
Ponceau S staining was used to control equal loading of the samples and protein transfer to 
membrane. Detection of caspase-3 forms was performed as it was described previously 
(Menshanov et al. 2006) with polyclonal primary rabbit antibodies (1:250 for intact and active 
caspase-3; 1:1000 for actin) and secondary alkaline phosphatase conjugated goat anti-rabbit 
antibody (1:500). Intensities of the signals for procaspase-3 and active caspase-3 bands were in 
a range of a linear dependence on these proteins amounts. 
  
Results and Discussion 
Dexamethasone administration on PD3 resulted in the arrest of body weight gain during 
the first 24 hours after injection. The weight increase was restored only 48 hours after injection, 
leading to a significant difference between dexamethasone-treated and control animals (Fig. 1; 
F(30,420)=2.000, p<0.0017). The administration of the equivalent dose of hydrocortisone was less 
detrimental, and animals recovered the body weight gain in 24 hours after injection (Fig. 1). The 
observed changes were the classic hallmark of glucocorticoid inhibitory action upon the 
metabolism of developing rats (He et al. 2004). Such catabolic action of corticosteroids is often 
followed by the activation of the key apoptotic enzyme – caspase-3 in different periferal tissues 
(Viegas et al. 2004). 
However, neither dexamethasone nor hydrocortisone did not affect the expression of 
active caspase-3 in the brainstem and cortex of treated rats in 6 or 24 hours after injection (Fig. 
2A-B; Cortex +6 hours - F(2,15)=0.315, p=0.734; Brainstem +6 hours – F(2,13)=0.166, p=0.849; 
Cortex +24 hours - F(2,17)=1.564, p=0.238; Brainstem +24 hours – F(2,17)=0.673, p=0.523). As 
the activation of caspase-3 is required for DNA fragmentation and morphological changes 
associated with apoptosis (Jänicke et al. 1998), the single administration of the low dose of 
glucocorticoids did not induce immediate upregulation of apoptosis, as it was shown earlier for 
higher doses in other brain regions (Noguchi et al. 2008). 
The level of procaspase-3 was also stable 6 and 24 hours after administration of 
dexamethasone or hydrocortisone (Fig. 2C-D; Cortex +6 hours - F(2,15)=0.003, p=0.997; 
Brainstem +6 hours – F(2,15)=0.132, p=0.878; Cortex +24 hours - F(2,17)=0.050, p=0.952; 
Brainstem +24 hours – F(2,17)=0.486, p=0.623). The lack of immediate changes in the levels of 
caspase-3 proenzyme after corticosteroid injection evidenced that transcription of caspase-3 
gene was not controlled directly by glucocorticoids neither in the brainstem nor in the cortex of 
developing rats. 
Nevertheless, a number of factors, such as brain mechanic injury, hypoxia and/or 
ischemia, are able to influence the intensity of apoptosis in the developing CNS not only in the 
first few hours after injection, but also in a later life (Bannova et al. 2004; Nakajima et al. 
2000). Such delayed activation of apoptosis might be as deleterious as the immediate one, and 
could lead to brain damage during development (Nakajima et al. 2000). The analysis of active 
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caspase-3 levels revealed the increased levels of this enzyme in the cortex of rats received 
dexamethasone 120 hours after injection (Fig. 2A-B; F(2,17)=5.362, p=0.016), similar to those 
observed earlier (Men’shanov et al. 2012). However, we did not find any significant upregulation 
of this apoptotic enzyme after administration of hydrocortisone. The observed difference in the 
action of these two glucocorticoids in the developing cortex could not be accounted for by the 
difference in the glucocorticoid receptor affinity for these ligands, as the equivalent dose of 
drugs was used in our experiment (Rivkees 2008). Developing cortex also lacked the expression 
of another hydrocortisone molecular target – mineralocorticoid receptors, and hydrocortisone 
should act in this tissue in the same way as its synthetic analogue (Czock et al. 2005). However, 
natural glucocorticoid could be inactivated by the 11β-HSD2 enzyme, which is expressed in this 
brain region during neonatal period, and its action might explain the observed difference 
(Robson et al. 1998). 
 
 
Figure 1. Day-to-day body weight gain after injection of hydrocortisone or dexamethasone on PD3. * - 
p<0.05 vs saline-treated animals of the same age. # - p<0.05 vs hydrocortisone-treated animals of the 
same age. 
There were no significant changes in the levels of active caspase-3 in the rat brainstem 
120 hours after injection (Fig. 2A-B; F(2,15)=0.447, p=0.648). The levels of procaspase-3 were 
also stable in both studied brain regions within this time point (Fig. 2A-B; Cortex - F(2,17)=0.314, 
p=0.735; Brainstem - F(2,17)=1.436, p=0.265). We also investigated whether dexamethasone-
mediated upregulation of active caspase-3 observed in the cortex was associated with the 
changes in the psychomotor development of our animals. The administration of synthetic 
glucocorticoid was followed by a number of developmental changes – there was a delay in the 
development of cliff avoidance reaction (Fig. 3; F(2,37)=2,981, p<0,063) and neonatal startle 
reflex (Fig. 4A; F(8,112)=4,620, p<0,00007), as well as a speed-up of the eyelid opening (Fig. 4B; 
F(8,112)=6,904, p<0,00001). Animals received dexamethasone were also less active than control 
ones (F(2,26)=16,515, p<0,00002). However, the injection of equivalent dose of hydrocortisone 
was followed only by a speed-up of the eyelid opening (Fig. 3-4), and no behavioral changes 
were observed in the rats received this drug.  
It also should be noted that there were no any developmental changes in first few days 
after injection of synthetic corticosteroid, and dexamethasone-induced behavioral changes 
coincided and might be linked with the caspase-3 activation pattern in the cortex by this drug. 
Thus, low-dose dexamethasone is more toxic than the low-dose hydrocortisone during neonatal 
development. 
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Figure 2. Expression of caspase-3 enzyme forms in the developing brain of neonatal rats in 6, 24 and 120 hours after 
injection of hydrocortisone and dexamethasone. Active caspase-3 levels in the cortex (A) and brainstem (B). 
















Figure 3. Development of cliff avoidance reaction * - p<0.05 vs saline-treated animals of the same age. # - p<0.1 vs 


















Figure 4. Developmental milestones after injection of hydrocortisone and dexamethasone. Development of neonatal 
startle reaction (A). Development of eyelid opening (B). * - p<0.05 vs saline-treated animals of the same age. # - 
p<0.1 vs saline-treated animals of the same age. 
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Conclusions 
In summary, the results of the present study evidence that administration of low dose 
dexamethasone was still associated with the developmental abnormalities in behavior and 
changes in the expression of active caspase-3. However, the injection of equivalent dose of 
hydrocortisone was followed only by a delay in the body weight gain and a speed-up of the 
eyelid opening, and no behavioral and molecular changes were observed in rats received this 
drug. Thus, lowering the dose of dexamethasone is not a therapeutic option, and other 
corticosteroids, such as hydrocortisone, should be considered to be used to prevent the 
respiratory distress syndrome in neonates. 
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